Alphalyse is a Danish contract research organization (CRO) specialising in protein chemistry, mass spectrometry, and bioinformatics. The firm’s co-founder & COO Ejvind Mørtz outlines its journey since its foundation in 2005, the evolution of the specialist CRO space, and the significance of AI and data integration.
The advantage of the company’s general mass spectrometry method is that it can be adapted for a variety of biologics, monoclonal antibodies, vaccines, viral vaccines, gene therapy products, and therapeutic proteins made in different manufacturing systems.
